1
1 In Vitro Diagnostics (IVD) - the UK opportunity Tests that can detect diseases, conditions or infections by analysis of blood, fluids, tissues and other samples Medical Technology In Vitro Diagnostic s Medical Imaging Digital Health & Care Point of Care (POC) Laboratory Medicine Pathology service testing, usually in hospital labs Testing at or near the patient to provide a rapid result outside the conventional lab environment UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Diagnostic Evidence Co- operatives NICE Diagnostics Assessment Programme BIVDA IVD Directive R&D based on unmet clinical needs Design prototype and manufactu re Health technolog y assessmen t and market entry Clinical studies Regulator y approval Supportive funding and investment environment Validate Clinicians and Patients Sh o w v a lu e Determine gaps in care Iter a ti ve dev e lo pment Test Efficiency Anonymised patient data

In Vitro Diagnostics (IVD) - the UK opportunity

  • Upload
    evelia

  • View
    118

  • Download
    3

Embed Size (px)

DESCRIPTION

UNLOCK YOUR GLOBAL BUSINESS POTENTIAL. In Vitro Diagnostics (IVD) - the UK opportunity. Medical Technology. R&D based on unmet clinical needs. Tests that can detect diseases, conditions or infections by analysis of blood, fluids, tissues and other samples. In Vitro Diagnostics. Medical - PowerPoint PPT Presentation

Citation preview

Laboratory Medicine Proposition Presentation

In Vitro Diagnostics (IVD) - the UK opportunityTests that can detect diseases, conditions or infections by analysis of blood, fluids, tissues and other samplesMedical TechnologyIn Vitro DiagnosticsMedicalImagingDigital Health & Care Point of Care (POC)Laboratory MedicinePathology service testing, usually in hospital labsTesting at or near the patient to provide a rapid result outside the conventional lab environment

UNLOCK YOUR GLOBAL BUSINESS POTENTIAL

Diagnostic Evidence Co-operatives NICE Diagnostics Assessment Programme BIVDAIVDDirective

R&D based on unmet clinical needsDesignprototype and manufactureHealth technology assessment and market entryClinical studiesRegulatoryapprovalSupportive funding and investment environmentValidateClinicians and PatientsShow valueDetermine gaps in careIterative developmentTest EfficiencyAnonymised patient data

#